FDA Submits Proposed Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, aiming to understand challenges and opportunities faced by compounding outsourcing facilities.